Carmenta Bioscience Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
Carmenta Bioscience General Information
Description
Developer of serum based diagnostic test for preeclampsia. The company focuses on maternal and fetal health by applying a systems biology approach to the diagnosis and prediction of preeclampsia.
Contact Information
Website
www.carmentabio.comCorporate Office
- 4240 Wilkie Way
- Palo Alto, CA 94306
- United States
Corporate Office
- 4240 Wilkie Way
- Palo Alto, CA 94306
- United States
Carmenta Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 29-Apr-2015 | Completed | Startup | |||
| 2. Accelerator/Incubator | 26-Aug-2013 | Completed | Product Development | |||
| 1. Seed Round | 07-Aug-2013 | $2M | $2M | Completed | Product Development |
Carmenta Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Carmenta Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Carmenta Bioscience Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Life Science Angels | Angel Group | Minority | ||
| StartX (US) | Accelerator/Incubator | Minority |
Carmenta Bioscience FAQs
-
When was Carmenta Bioscience founded?
Carmenta Bioscience was founded in 2012.
-
Where is Carmenta Bioscience headquartered?
Carmenta Bioscience is headquartered in Palo Alto, CA.
-
What is the size of Carmenta Bioscience?
Carmenta Bioscience has 4 total employees.
-
What industry is Carmenta Bioscience in?
Carmenta Bioscience’s primary industry is Biotechnology.
-
Is Carmenta Bioscience a private or public company?
Carmenta Bioscience is a Private company.
-
What is Carmenta Bioscience’s current revenue?
The current revenue for Carmenta Bioscience is .
-
How much funding has Carmenta Bioscience raised over time?
Carmenta Bioscience has raised $2M.
-
Who are Carmenta Bioscience’s investors?
Life Science Angels and StartX (US) have invested in Carmenta Bioscience.
-
When was Carmenta Bioscience acquired?
Carmenta Bioscience was acquired on 29-Apr-2015.
-
Who acquired Carmenta Bioscience?
Carmenta Bioscience was acquired by Biora Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
